Single User License
INR 168900
Site License
INR 337800
Corporate User License
INR 506700

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Prader-Willi Syndrome PWS Global Clinical Trials Review, H2

Prader-Willi Syndrome PWS Global Clinical Trials Review, H2


  Request for Sample Report

Executive Summary

Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H2, 2015

GlobalData's clinical trial report, "Prader-Willi Syndrome (PWS) Global Clinical Trials Review, H2, 2015" provides an overview of Prader-Willi Syndrome (PWS) clinical trials scenario. This report provides top line data relating to the clinical trials on Prader-Willi Syndrome (PWS). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Prader-Willi Syndrome (PWS) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Clinical Trials by G7 Countries: Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials 13

Clinical Trials by Phase in G7 Countries 14

Clinical Trials in G7 Countries by Trial Status 15

Clinical Trials by Phase 16

In Progress Trials by Phase 17

Clinical Trials by Trial Status 18

Clinical Trials by End Point Status 19

Unaccomplished Trials of Prader-Willi Syndrome (PWS) 20

Subjects Recruited Over a Period of Time 21

Clinical Trials by Sponsor Type 22

Prominent Sponsors 23

Top Companies Participating in Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials 24

Prominent Drugs 25

Latest Clinical Trials News on Prader-Willi Syndrome (PWS) 26

Jun 04, 2015: Rhythm Initiates Two Phase 2 Clinical Trials of Setmelanotide in Rare Genetic Disorders of Obesity Caused by MC4 Pathway Deficiencies 26

May 28, 2015: Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome 27

May 08, 2015: Zafgen Presents Positive Safety And Efficacy Data From Phase 2 Trial Of Beloranib In Severe Obesity And Proof Of Concept Trial In Prader-Willi Syndrome At ECO 2015 27

Clinical Trial Profiles 29

Clinical Trial Overview of Top Companies 29

Novo A/S 29

Clinical Trial Overview of Novo A/S 29

Zafgen Inc. 30

Clinical Trial Overview of Zafgen Inc. 30

Novartis AG 31

Clinical Trial Overview of Novartis AG 31

LG Life Sciences, Ltd. 32

Clinical Trial Overview of LG Life Sciences, Ltd. 32

Ferring International Center S.A. 33

Clinical Trial Overview of Ferring International Center S.A. 33

Essentialis, Inc. 34

Clinical Trial Overview of Essentialis, Inc. 34

Eli Lilly and Company 35

Clinical Trial Overview of Eli Lilly and Company 35

Corporacion Parc Tauli 36

Clinical Trial Overview of Corporacion Parc Tauli 36

Chong Kun Dang Pharmaceutical Corp. 37

Clinical Trial Overview of Chong Kun Dang Pharmaceutical Corp. 37

Alize Pharma SAS 38

Clinical Trial Overview of Alize Pharma SAS 38

Clinical Trial Overview of Top Institutes / Government 39

University Hospital, Toulouse 39

Clinical Trial Overview of University Hospital, Toulouse 39

Aintree University Hospitals NHS Foundation Trust 40

Clinical Trial Overview of Aintree University Hospitals NHS Foundation Trust 40

Dutch Growth Research Foundation 41

Clinical Trial Overview of Dutch Growth Research Foundation 41

Eunice Kennedy Shriver National Institute of Child Health and Human Development 42

Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 42

Garvan Institute of Medical Research 43

Clinical Trial Overview of Garvan Institute of Medical Research 43

Radboud University Nijmegen Medical Centre 44

Clinical Trial Overview of Radboud University Nijmegen Medical Centre 44

The Children's Mercy Hospital 45

Clinical Trial Overview of The Children's Mercy Hospital 45

University of Florida 46

Clinical Trial Overview of University of Florida 46

Vancouver General Hospital 47

Clinical Trial Overview of Vancouver General Hospital 47

Weill Cornell Medical College 48

Clinical Trial Overview of Weill Cornell Medical College 48

Five Key Clinical Profiles 49

Appendix 70

Abbreviations 70

Definitions 70

Research Methodology 71

Secondary Research 71

About GlobalData 72

Contact Us 72

Disclaimer 72

Source 73

List of Figures

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13

Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

GlobalData Methodology 71

List of Tables

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Region, 2015* 7

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Proportion of Prader-Willi Syndrome (PWS) to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 13

Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14

Prader-Willi Syndrome (PWS) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Phase, 2015* 16

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17

Prader-Willi Syndrome (PWS) Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19

Prader-Willi Syndrome (PWS) Therapeutics, Global, Terminated Clinical Trials, 2015* 20

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21

Prader-Willi Syndrome (PWS) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 29

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Zafgen Inc., 2015* 30

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 31

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by LG Life Sciences, Ltd., 2015* 32

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015* 33

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Essentialis, Inc., 2015* 34

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 35

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Corporacion Parc Tauli, 2015* 36

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chong Kun Dang Pharmaceutical Corp., 2015* 37

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alize Pharma SAS, 2015* 38

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Toulouse, 2015* 39

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Aintree University Hospitals NHS Foundation Trust, 2015* 40

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Dutch Growth Research Foundation, 2015* 41

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2015* 42

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Garvan Institute of Medical Research, 2015* 43

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University Nijmegen Medical Centre, 2015* 44

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Mercy Hospital, 2015* 45

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2015* 46

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vancouver General Hospital, 2015* 47

Prader-Willi Syndrome (PWS) Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2015* 48

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Novo A/S

Zafgen Inc.

Novartis AG

LG Life Sciences, Ltd.

Ferring International Center S.A.

Essentialis, Inc.

Eli Lilly and Company

Corporacion Parc Tauli

Chong Kun Dang Pharmaceutical Corp.

Alize Pharma SAS

Prader-Willi Syndrome (PWS) Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Prader-Willi Syndrome (PWS), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com